biostudies-literatureUnknown19(2)Montez de Sousa IR<h4>Background</h4>Kidney transplantation (KT) is the preferred treatment for paediatric patients with kidney failure, but information on trends in paediatric KT in Europe is lacking. We aimed to report on time trends in paediatric (0-17 years) KT rates and recipient characteristics in Europe between 2010 and 2021.<h4>Methods</h4>Thirty-one countries contributing data from 2010 to 2021 on paediatric KT to the European Society for Paediatric Nephrology/European Renal Association Registry were included. We reported trends in KT rates [per million age-related population (pmarp)], overall and by patient subgroup for Europe, and at macro-economic and country-specific levels. We also reported clinical variables in the first year post-KT. The 2020-21 period was analysed separately to account for Clinical kidney journalsfag012https://www.ebi.ac.uk/biostudies/studies/S-EPMC12910316biostudies-literatureTrends in the epidemiology of paediatric kidney transplantation in Europe between 2010 and 2021: an ESPN/ERA Registry study.PMC12910316Mihneva-Kirilova GFomina SPDonmez ORocha LBakkaloglu SAShtiza DParmentier CMagadi WJankauskiene ASpasojevic BPodracka LJager KJBaiko SLundgren TMolchanova MSMontez de Sousa IRBonthuis MJahnukainen TZagozdzon IEdvardsson VNovljan GStel VSReusz GGjerstad ACAbazi-Emini NHogan JStojanovic JAskiti VSorensen SSVondrak KTonshoff BTen Dam MAGJfalseTrends in the epidemiology of paediatric kidney transplantation in Europe between 2010 and 2021: an ESPN/ERA Registry study.<h4>Background</h4>Kidney transplantation (KT) is the preferred treatment for paediatric patients with kidney failure, but information on trends in paediatric KT in Europe is lacking. We aimed to report on time trends in paediatric (0-17 years) KT rates and recipient characteristics in Europe between 2010 and 2021.<h4>Methods</h4>Thirty-one countries contributing data from 2010 to 2021 on paediatric KT to the European Society for Paediatric Nephrology/European Renal Association Registry were included. We reported trends in KT rates [per million age-related population (pmarp)], overall and by patient subgroup for Europe, and at macro-economic and country-specific levels. We also reported clinical variables in the first year post-KT. The 2020-21 period was analysed separately to account for 2026-01-01T00:00:00Z2026 Feb2026-07-16T11:55:41.041Z2026-07-09T10:52:12.698ZS-EPMC129103164171004610.1093/ckj/sfag012